Lung disease drug may slow aging

A small clinical study found that rentosertib, an experimental drug developed to treat a serious lung disease, may also temporarily make patients appear biologically younger by three to four years based on blood protein changes. The research, involving patients with idiopathic pulmonary fibrosis, used multiple aging tests and compared results with large datasets, but the findings are preliminary and do not confirm anti-aging effects. Larger, longer-term trials are needed to determine if the drug can truly slow aging or improve overall health.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل